Hot Pursuit     08-Nov-23
Biocon Ltd spurts 0.78%, up for five straight sessions
Biocon Ltd is quoting at Rs 227.1, up 0.78% on the day as on 12:49 IST on the NSE. The stock is down 18.66% in last one year as compared to a 7.03% gain in NIFTY and a 18.62% gain in the Nifty Pharma.

Biocon Ltd rose for a fifth straight session today. The stock is quoting at Rs 227.1, up 0.78% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.14% on the day, quoting at 19432.95. The Sensex is at 64961.62, up 0.03%. Biocon Ltd has dropped around 12.8% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has dropped around 2.72% in last one month and is currently quoting at 15271.75, up 1.59% on the day. The volume in the stock stood at 18.09 lakh shares today, compared to the daily average of 32.25 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 228.25, up 0.86% on the day. Biocon Ltd is down 18.66% in last one year as compared to a 7.03% gain in NIFTY and a 18.62% gain in the Nifty Pharma index.

The PE of the stock is 253.15 based on TTM earnings ending June 23.

Previous News
  Benchmarks trade falt; oil & gas shares rally for 9th day in row
 ( Market Commentary - Mid-Session 24-May-24   12:33 )
  Sensex spurts 901 pts; Nifty above 22,400; European mkt opens higher
 ( Market Commentary - Mid-Session 28-Mar-24   13:36 )
  Biocon consolidated net profit rises 167.80% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   17:28 )
  Biocon jumps after inking pact with Biomm SA
 ( Hot Pursuit - 18-Apr-24   11:47 )
  Barometers pares all gains ; realty shares decline
 ( Market Commentary - Mid-Session 24-May-24   10:36 )
  Biocon Ltd up for five straight sessions
 ( Hot Pursuit - 19-Feb-24   13:00 )
  Market at day’s high; VIX climbs 3.96%; realty shares advance
 ( Market Commentary - Mid-Session 18-Apr-24   12:37 )
  Biocon to conduct board meeting
 ( Corporate News - 22-Jul-23   10:58 )
  Biocon Biologics update on USFDA's CRL issued to partner Viatris (Mylan)
 ( Corporate News - 13-Feb-23   09:20 )
  Biocon consolidated net profit declines 5.77% in the March 2022 quarter
 ( Results - Announcements 29-Apr-22   07:59 )
  Biocon surges after signing exclusive licensing deal for Liraglutide with Handok
 ( Hot Pursuit - 24-May-24   09:45 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top